Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect? - Wikidata - awgldk - TriplyDB

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

http://www.wikidata.org/entity/Q57688960

about

Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study.Age-dependent differential crosstalk between alpha(1)-adrenergic and angiotensin receptors.Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartan.Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.Comparison of chronic systolic heart failure guideline adherence for two ambulatory clinics.Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.Comparative persistence on β-blockers versus calcium channel blockers for ventricular rate control in nonelderly patients with atrial fibrillation.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

P2860

Q37141972-C577B478-6112-4933-BF19-BC0E1DF5EBB3 Q37319854-71E9AD9D-D39E-417F-9C50-4DF95A0CD835 Q37661553-4F8D314C-1306-46B7-867B-EC5C4D523BCD Q37904934-A4093689-17C0-4ADC-9610-76C5C8D66A53 Q38242818-F2EF5EFD-3B10-4EB2-B190-37F23770CF54 Q42069095-9E494548-547E-41BB-A77F-EFA43CFE7C15 Q43654157-A840FCAE-4522-46A5-A9D1-1E067ED93236 Q52347539-E85A5C0B-3771-453E-870E-5B4BFCCFB81C

P2860

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

http://www.wikidata.org/entity/Q57688960

description

article

@en

im April 2007 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2007

@uk

name

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@en

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@nl

type

label

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@en

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@nl

prefLabel

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@en

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@nl

P1433

Q57688960-BDDDD044-7778-4E57-8F15-89E3BE4676FB

P1476

Q57688960-D9623811-1470-40B4-9D61-79AE5E18AFD1

P2093

Q57688960-2F95316E-19A1-4F28-8911-8A2BCB175016

Q57688960-B4A44A72-6EB1-4736-BB02-220877256C36

Q57688960-EECE5276-9505-483B-9C1C-08A92AF357BC

Q57688960-FE0C1320-D6EF-48F4-A902-3778E1948265

P2860

Q57688960-0B4DF380-5E08-4F64-8BD1-DC33E2481A43

Q57688960-19765C91-2900-4159-B4FD-D1C71EC21B63

Q57688960-199B51B6-A735-4D18-8026-1EF4052DB600

Q57688960-19B87204-AA1F-40E2-A91C-3C70F33A8654

Q57688960-1C76A149-0C9B-402C-919B-94EC2D6FEC3E

Q57688960-301271EC-2EF7-4D2D-9877-4116BE8DD3AB

Q57688960-4389D0C9-21CB-4AEF-ABD2-5428703E35A5

Q57688960-4436A179-4F06-46FF-BF03-6E5CEFBFAC03

Q57688960-57B9A9CB-3E5A-4631-8B67-4AB685339E35

Q57688960-651E0FBD-9286-4D51-9752-97EDEA66B4E8

P304

Q57688960-609767AB-0884-47CA-AD5D-A5C5967B262B

P31

Q57688960-48A8F0B7-9C25-4035-980F-9F10BC32A4CE

P356

Q57688960-4AFF5EB7-DE98-497A-831F-695D30085526

P407

Q57688960-934BCC23-9053-4672-9E0D-89A0C8236E11

P433

Q57688960-021FA038-ACC5-4FE7-AFA9-9522F9313C9D

P478

Q57688960-C14C7A84-D130-4D13-B215-6B9AF1552BF1

P50

Q57688960-2FAFF37F-05A2-4158-A7C7-E0767775B321

Q57688960-40E930C8-514D-4FC2-BFCC-B9BCD3389D3C

P577

Q57688960-250CF977-56E8-461D-85D5-7713A05366C2

P698

Q57688960-FCC243D3-71FB-4E73-A61D-5BD32E6A7A93

P356

P1433

Pharmacotherapy

P1476

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect?

@en

P2093

Hassan Behlouli

http://www.w3.org/2001/XMLSchema#string

Karin Humphries

http://www.w3.org/2001/XMLSchema#string

Marie Hudson

http://www.w3.org/2001/XMLSchema#string

Richard Sheppard

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

Are drugs within a class interchangeable?

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.

P304

526-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.27.4.526

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17381379

http://www.w3.org/2001/XMLSchema#string